The rise of TIM-3: A promising immune target in diffuse midline gliomas

Iker Ausejo-Mauleon; Sara Nuin; Marta M. Alonso

doi:10.1002/ctm2.1536

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (1) : e1536 DOI: 10.1002/ctm2.1536

EDITORIAL

The rise of TIM-3: A promising immune target in diffuse midline gliomas

Iker Ausejo-Mauleon ¹^,²^,³^,^†
, Sara Nuin ¹^,²^,³
, Marta M. Alonso ¹^,²^,³^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Iker Ausejo-Mauleon,Sara Nuin,Marta M. Alonso. The rise of TIM-3: A promising immune target in diffuse midline gliomas. Clinical and Translational Medicine, 2024, 14(1): e1536 DOI:10.1002/ctm2.1536

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.